Back to Search Start Over

Nanomedicines: addressing the scientific and regulatory gap.

Authors :
Tinkle, Sally
McNeil, Scott E.
Mühlebach, Stefan
Bawa, Raj
Borchard, Gerrit
Barenholz, Yechezkel (Chezy)
Tamarkin, Lawrence
Desai, Neil
Source :
Annals of the New York Academy of Sciences; Apr2014, Vol. 1313, p35-56, 22p
Publication Year :
2014

Abstract

Nanomedicine is the application of nanotechnology to the discipline of medicine: the use of nanoscale materials for the diagnosis, monitoring, control, prevention, and treatment of disease. Nanomedicine holds tremendous promise to revolutionize medicine across disciplines and specialties, but this promise has yet to be fully realized. Beyond the typical complications associated with drug development, the fundamentally different and novel physical and chemical properties of some nanomaterials compared tomaterials on a larger scale (i.e., their bulk counterparts) can create a unique set of opportunities as well as safety concerns, which have only begun to be explored. As the research community continues to investigate nanomedicines, their efficacy, and the associated safety issues, it is critical to work to close the scientific and regulatory gaps to assure that nanomedicine drives the next generation of biomedical innovation. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00778923
Volume :
1313
Database :
Complementary Index
Journal :
Annals of the New York Academy of Sciences
Publication Type :
Academic Journal
Accession number :
97231731
Full Text :
https://doi.org/10.1111/nyas.12403